Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Debt / NOTE 1.500% 4/1
-
Number of holders
-
23
-
Total 13F principal, excl. options
-
167,332,000
-
Principal change
-
-22,240,000
-
Total reported value, excl. options
-
$185,926,528
-
Value change
-
-$24,706,873
-
Number of buys
-
6
-
Number of sells
-
-8
-
Price
-
$1.11
Significant Holders of COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 as of Q4 2021
28 filings reported holding 19249HAB9 - COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 as of Q4 2021.
COHERUS BIOSCIENCES INC - NOTE 1.500% 4/1 has 23 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $167,332,000 of principal
.
Largest 10 bondholders include CITADEL ADVISORS LLC ($35,350,000 of principal), LAZARD ASSET MANAGEMENT LLC ($26,000,000 of principal), UBS ASSET MANAGEMENT AMERICAS INC ($23,500,000 of principal), Opti Capital Management, LP ($17,650,000 of principal), AQR Arbitrage LLC ($14,645,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($14,500,000 of principal), D. E. Shaw & Co., Inc. ($10,500,000 of principal), CALAMOS ADVISORS LLC ($5,467,000 of principal), SHENKMAN CAPITAL MANAGEMENT INC ($4,682,000 of principal), and MACQUARIE GROUP LTD ($3,888,000 of principal).
This table shows the top 23 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.